Oncolmmune Inc.;Martin DEVENPORT;PAN ZHENG;YANG LIU
发明人:
YANG LIU,PAN ZHENG,Martin DEVENPORT
申请号:
IL25998818
公开号:
IL259988D0
申请日:
2018.06.13
申请国别(地区):
IL
年份:
2018
代理人:
摘要:
This invention relates to compositions of chimeric and humanized antibodies that bind to the human CTLA4 molecule and their use in cancer immunotherapy and for reduction of autoimmune side effects compared to other immunotherapeutic agents.